The latest announcement is out from SkiStar AB Class B ( ($SE:SKIS.B) ). SkiStar AB announced it will release its Interim Report for the first ...

Austral Gold Releases Updated Corporate Presentation. Sydney, Australia--(Newsfile Corp. - 10, 2025) - Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company), an ...

HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that new clinical data from ...

Akari Therapeutics ( ($AKTX) ) just unveiled an announcement. On December 8, 2025, Akari Therapeutics, Plc prepared an investor presentation for ...

Blueprint Medicines, a Sanofi company, today announced updated data reinforcing the clinical efficacy and safety of long-term ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...

Graham Holdings Company ( GHC) Analyst/Investor Day December 9, 2025 1:00 PM EST ...

Netflix has admitted it did not attribute any value to Warner Bros.’ video game business in its $82.7 billion acquisition deal, sparking concern for the future of everything from Mortal Kombat to ...

Cohort 1 data from multiple dose ReSPECT- Leptomeningeal Metastases (LM) trial showed no dosage limiting toxicity ...

TopBuild Corp., (NYSE:BLD) a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United ...

Detailed price information for Perspective Therapeutics Inc (CATX-A) from The Globe and Mail including charting and trades.

Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) (“Myriad” or the “Company”) is pleased to announce that it has earned a 75% ...